I am speculating that there is already an offer on the table....guaranteed M/A coming in the first quarter of this year. BIG PHARMA's team will short stock to drive price down and then make their offer for buyout! Its the commonest game we play in M/A. Guarantee that there is an offer of at least $12 to $15 already on the table....which is steal. CABO has gotten phenomenal potential that will be used in a multitude of malignancies. They don't care about Medullary Ca......Will be a bidding war between Biogen and Roche for this company. You heard it here first!
Yeah...right. Unusual action in the stock? Gaping up every day? The options market in Switzerland doing strange things? No offense...and believe me I have a boatload of the stock and Leaps and I'd love to see it...but once again...what are you smoking? Could a takeover be in the works? Of course. Is there any sign of it at present? Of course not.
I have heard that there were multiple offers with partnering, not necessarily a T.O. You may have something up your sleve there. Recently, I hear from someone who worked there that their new Position for hire may invite some from a Large Pharma. Just a note, as much as I have discussed Exel's potential for a T.O, I have no reasoning to see it go below $30.00 . It maybe this Summer or within strinking distance of ASCO 2013. Mike may surprise us all with a potential partnership with a couple of our Trials. This does not entail Exel's primary " Proatate" Trials. Exel have the option with partnering with 9 of their immediate Trials. Which ones could it be? Take Prostate and Melanoma out and there are 9 to choose from, and don't forget Roche's already partnered Compound. Make your pick?